Compare NHC & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NHC | CC |
|---|---|---|
| Founded | 1971 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | 1997 | 2014 |
| Metric | NHC | CC |
|---|---|---|
| Price | $211.56 | $17.81 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $20.11 |
| AVG Volume (30 Days) | 150.0K | ★ 2.7M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.46% | 1.33% |
| EPS Growth | ★ 17.46 | N/A |
| EPS | ★ 2.27 | N/A |
| Revenue | $1,517,781,000.00 | ★ $6,638,000,000.00 |
| Revenue This Year | N/A | $6.15 |
| Revenue Next Year | N/A | $5.95 |
| P/E Ratio | $94.35 | ★ N/A |
| Revenue Growth | ★ 16.09 | 7.36 |
| 52 Week Low | $93.54 | $10.44 |
| 52 Week High | $220.86 | $28.67 |
| Indicator | NHC | CC |
|---|---|---|
| Relative Strength Index (RSI) | 58.42 | 36.23 |
| Support Level | $154.31 | $15.99 |
| Resistance Level | N/A | $23.63 |
| Average True Range (ATR) | 6.60 | 1.25 |
| MACD | 0.07 | -0.25 |
| Stochastic Oscillator | 55.83 | 15.07 |
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.